Leading Pharma Companies Unite at Social Media Conference to Share Digital Innovation Strategies
核心洞察
Twenty senior executives from major pharmaceutical companies including Pfizer, GSK, Merck (搜索), and AstraZeneca will convene to discuss compliant social media engagement strategies in London.
The conference aims to address critical challenges in pharmaceutical digital communications, focusing on patient and healthcare professional engagement while maintaining regulatory compliance.
Industry leaders will share insights on leveraging cutting-edge platform technologies and content strategies to demonstrate measurable impact and secure organizational buy-in for social media initiatives.
Top pharmaceutical industry leaders are set to gather in London for a groundbreaking conference focused on revolutionizing social media engagement in the healthcare sector. The one-day event, scheduled for June 25th at One America Square in Central London, will feature 20 senior executives from the world's leading pharmaceutical companies sharing their expertise on compliant digital engagement strategies.
Digital Innovation Leaders Share Best Practices
The conference brings together an impressive roster of digital transformation experts, including Dr. Rene Rust, Head of Global External Communications at GSK Vaccines, and Sarah Holiday, Social Media Strategy Lead for Pfizer's operations across Europe, Japan, South Korea, Australia, and New Zealand. These industry veterans will present fresh perspectives on balancing regulatory compliance with effective digital engagement.
Charlotte Frappell, Associate Director of Digital Communications at AstraZeneca, and Haider Alleg, Global Head of Digital Marketing at Ferring International (搜索), are among the speakers who will address how pharmaceutical companies can develop customer-centric approaches while navigating complex regulatory requirements.
Compliance and Strategic Implementation
The event places special emphasis on regulatory compliance, featuring presentations from key compliance experts including Jill Pearcy, Director of ABPI Code Engagement, and Evgeny Tilezhinsky, Law and Compliance Lead for Bristol-Myers Squibb (搜索) in Central and Eastern Europe. Their sessions will focus on developing compliant social media strategies that effectively engage both patients and healthcare professionals.
Innovation and Digital Transformation
Several sessions will explore cutting-edge digital innovations and their implementation in pharmaceutical marketing. Maria de Freitas, Experienced Growth Hacking Manager at Leo Innovation Lab, will share insights on leveraging new technologies for enhanced engagement. The conference will also feature presentations on measuring social media impact and securing organizational support for digital initiatives.
Multi-Channel Strategy and Global Perspectives
The conference agenda includes discussions on integrated multi-channel approaches, with speakers such as Frédéric Ohayon, Digital Multichannel & CRM Director at AstraZeneca, and Berfi Demirbilek, Global Integrated Multichannel Marketing & Sales Manager at Bayer, sharing their experiences in developing comprehensive digital strategies.
Regional perspectives will be addressed by speakers including Muchena Zigomo, Associate Director of Regional Communications at MSD, and Javier Télez Iglesias, Communications & Government Affairs Manager for Teva Pharmaceuticals in Spain and Portugal, providing attendees with insights into market-specific challenges and solutions.